{
  "id": 15007856,
  "title": "RNAi drug developer City climbs after upsized IPO",
  "url": "https://urgent.news/2026/10/16/rnai-drug-developer-city-climbs-after-upsized-ipo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T17:24:05.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4653945-rnai-drug-developer-city-climbs-after-upsized-ipo?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "City Therapeutics prices upsized IPO at $18 per share",
        "url": "https://urgent.news/2026/10/16/city-therapeutics-prices-upsized-ipo-at-18-per-share",
        "published": "2026-10-16T02:40:35.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "City Therapeutics lands $200M IPO as it builds an Alnylam 2.0 in RNAi field",
        "url": "https://urgent.news/2026/10/16/city-therapeutics-lands-200m-ipo-as-it-builds-an-alnylam-2-0-in-rnai",
        "published": "2026-10-16T10:17:21.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}